BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9032375)

  • 1. Mutational analysis of the oligomer assembly domain in the transmembrane subunit of the Rous sarcoma virus glycoprotein.
    Einfeld DA; Hunter E
    J Virol; 1997 Mar; 71(3):2383-9. PubMed ID: 9032375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions.
    Perez LG; Davis GL; Hunter E
    J Virol; 1987 Oct; 61(10):2981-8. PubMed ID: 3041017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the TM protein of Rous sarcoma virus in the absence of SU shows that this domain is capable of oligomerization and intracellular transport.
    Einfeld DA; Hunter E
    J Virol; 1994 Apr; 68(4):2513-20. PubMed ID: 8139033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein.
    Lavillette D; Boson B; Russell SJ; Cosset FL
    J Virol; 2001 Apr; 75(8):3685-95. PubMed ID: 11264358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the Rous sarcoma virus env gene that affect the transport and subcellular location of the glycoprotein products.
    Wills JW; Srinivas RV; Hunter E
    J Cell Biol; 1984 Dec; 99(6):2011-23. PubMed ID: 6094591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein.
    Spies CP; Compans RW
    Virology; 1994 Aug; 203(1):8-19. PubMed ID: 8030287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins.
    Berlioz-Torrent C; Shacklett BL; Erdtmann L; Delamarre L; Bouchaert I; Sonigo P; Dokhelar MC; Benarous R
    J Virol; 1999 Feb; 73(2):1350-61. PubMed ID: 9882340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
    Celma CC; Paladino MG; González SA; Affranchino JL
    Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the transmembrane domain proximal region of the human T-cell leukemia virus type 1 fusion glycoprotein gp21 has distinct roles in the prefusion and fusion-activated states.
    Wilson KA; Maerz AL; Poumbourios P
    J Biol Chem; 2001 Dec; 276(52):49466-75. PubMed ID: 11595747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The entire SU subunit is required for the incorporation of the HIV-1 envelope glycoprotein complex into virions.
    Li YY; Perez LG
    Virus Genes; 1997; 14(3):211-23. PubMed ID: 9311566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations within the putative membrane-spanning domain of the simian immunodeficiency virus transmembrane glycoprotein define the minimal requirements for fusion, incorporation, and infectivity.
    West JT; Johnston PB; Dubay SR; Hunter E
    J Virol; 2001 Oct; 75(20):9601-12. PubMed ID: 11559792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells.
    LaBranche CC; Sauter MM; Haggarty BS; Vance PJ; Romano J; Hart TK; Bugelski PJ; Marsh M; Hoxie JA
    J Virol; 1995 Sep; 69(9):5217-27. PubMed ID: 7636963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino-terminal deletion mutants of the Rous sarcoma virus glycoprotein do not block signal peptide cleavage but can block intracellular transport.
    Hardwick JM; Shaw KE; Wills JW; Hunter E
    J Cell Biol; 1986 Sep; 103(3):829-38. PubMed ID: 3017996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.
    Delos SE; Godby JA; White JM
    J Virol; 2005 Mar; 79(6):3488-99. PubMed ID: 15731243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport and processing of the Rous sarcoma virus Gag protein in the endoplasmic reticulum.
    Krishna NK; Weldon RA; Wills JW
    J Virol; 1996 Mar; 70(3):1570-9. PubMed ID: 8627676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A charged amino acid substitution within the transmembrane anchor of the Rous sarcoma virus envelope glycoprotein affects surface expression but not intracellular transport.
    Davis GL; Hunter E
    J Cell Biol; 1987 Sep; 105(3):1191-203. PubMed ID: 2821009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomeric structure of a prototype retrovirus glycoprotein.
    Einfeld D; Hunter E
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8688-92. PubMed ID: 2847170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.
    Duda A; Lüftenegger D; Pietschmann T; Lindemann D
    J Virol; 2006 Aug; 80(16):8158-67. PubMed ID: 16873272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
    Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
    J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.
    Katz E; Wolffe EJ; Moss B
    J Virol; 1997 Apr; 71(4):3178-87. PubMed ID: 9060681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.